Novartis' Jakavi turns out positive PhIII results in PV; 'Are you prepared for anaphylaxis?' Adrian Peterson asks;

> Phase III data show polycythemia vera patients on Novartis' ($NVS) Jakavi achieved significant improvement in disease control. Release

> Johnson & Johnson ($JNJ) has shifted its U.S. media buying account to OMD, part of the Omnicom Media Group division of the Omnicom Group. More (sub. req.)

> AbbVie ($ABBV), Astellas and Roche ($RHHBY) have been nominated for the Pegasus Award for In-House Team of the Year at Communiqué. More

> Brand experience agency SSG Create has secured Botox-maker Allergan ($AGN) as a client. Report

> IDEA Pharma has appointed UPenn research specialist Rick Ritacco to its New York practice. Release

> Jack Morton Worldwide has opened an office in Düsseldorf, Germany, following client wins with Novartis ($NVS) and Merck Serono. More

> Johnson & Johnson ($JNJ), a World Cup sponsor through its Listerine and Regaine brands, has helped fuel growth at sponsorship agency Prism. More

And Finally... EpiPen maker Mylan ($MYL) and NFL star Adrian Peterson are calling on Americans to learn to be aware and prepared for anaphylaxis. Release

Suggested Articles

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Call it a fall sports bounce. TV ad spending bumped up in August with the partial return of professional sports, and that included pharma buyers.

GI cancers are stubborn, as plenty of oncology drugmakers know. But BMS' Opdivo has broken through with two potentially practice-changing trials.